Bioequivalence and Bioavailability Forum

Dear colleagues

can you advise and share your practices about the following text in the latest M10 guideline for the bioanalytical method validation?

"For non-accuracy and precision validation runs, low, medium and high QCs may be analysed in duplicate. These QCs, along with the calibration standards, will provide the basis for the acceptance or rejection of the run."

are the stability runs which contains low and high QC levels are considered non-accuracy run?
what are the non-accuracy runs during the method validation and how can the duplicates of the low, med and high QCs be assessed to decide the run accepted or rejected if the run itself not designed for the accuracy (recovery as example or carry over).

if we have an analytical method validated without including these replicates, should the method be re-validated?

please advise and share your thoughts, thanks in advance.